August 26, 2026 (MLN): This is a forensic review of Agro Processors & Atmospheric Gases Limited's PSX Main Board IPO, our own findings first, the CEO's written answers in full, and where we land.

1. Forty-Five Years in Your Kitchen, Now on the Market

Chances are, APAG has been in your kitchen without you ever noticing the name on the corporate filing.

For 45 years, the Karachi-based company has been quietly behind some of Pakistan's most recognisable household staples, the Soya Supreme bottle of cooking oil on the shelf, the Taqat and Champion banaspati used in countless kitchens for everyday cooking and baking, and the Smart sauces that show up on dining tables from home kitchens to hotel buffets. It's the kind of business that doesn't announce itself loudly, but rarely leaves the pantry.

Now, that quiet, four-decade-old family business is stepping into the spotlight, raising up to PKR 2.6 billion from the public on PSX's Main Board.

Shares are being offered at a face value of PKR 2.00 each, the floor price of PKR 32.00 represents a premium of PKR 30.00 per share over that face value. This follows the company's 1:50 share split completed in April 2026, which reduced face value from the pre-split PKR 100.00 to the current PKR 2.00 and proportionally increased the share count, primarily to improve retail affordability and accessibility ahead of listing.

Before writing this, we read the 295-page prospectus line by line, then sent the CEO APAG Mr. Ahmad Aziz Ghulam Hussain 18 direct questions. He answered every one, unedited, on the record, reproduced in full in Section 4.

2. Deal Snapshot

3. Our Findings

Everything below is built from figures the prospectus itself discloses, not taken at face value.

3.1 The Valuation Math, Stress-Tested

Everything below is built from figures the prospectus itself discloses, not taken at face value.

The prospectus's DCF starts from EBIT, which appears to include Other Income, income from short-term investments, rather than the core edible-oil business. That income seems to be embedded in the cash flows used to value the company, while the cash balance is also added separately at the end of the calculation, which could mean a portion of the same value is being reflected twice. Separately, the beta used to discount those cash flows suggests APAG is being treated as somewhat less risky than the average listed company, even though its cost base is heavily linked to the US dollar and global commodity prices.

When we looked at both points using the prospectus's own model and its own formulas, the resulting fair value came out noticeably closer to the floor price than the 31% discount being advertised, in some readings, close enough that the floor may not represent much of a discount at all.

The sector-multiple comparison raises a similar, softer question. The prospectus's own table discloses both a weighted-average peer P/E and a median; the average appears to be lifted by a few higher-multiple names that may not closely resemble APAG's scale or margin profile. Measured against the median instead, the floor's apparent discount looks considerably smaller than the headline figure suggests.

The sector-multiple comparison tells a similar story. The prospectus's own table discloses both a 21.51x weighted-average P/E and a 15.08x median; the average is pulled up by outliers (Mitchells 60.7x, Fauji Foods 37.2x, Ismail Industries 32.2x) that don't resemble APAG. Against the median, the floor is only a ~4.4% discount, not 43%.

3.2 Capacity Expansion Is Running Ahead of Demand

Refinery utilization: 42.54% (FY23), 42.98% (FY24), 45.89% (FY25), never above 46%. Roughly PKR 522mn, over a quarter of the raise, funds a 33% capacity increase against three years of sub-46% utilization.

3.3 Earnings Quality

FY25's PKR 217.66mn interest-income line, stripped out at the prospectus's own effective tax rate, brings recomputed PAT to roughly PKR 426mn, well below the PKR 557mn reported. The 12.26x trailing P/E used to anchor the floor rests partly on income that isn't core to the business.

3.4 A Second Look Turned Up More

Going back through the prospectus a second time, purely to check what the first pass might have missed, surfaced a handful of things worth flagging on their own. Facility Offer Letters with five lenders, Allied Bank, Bank of Punjab, Habib Bank, Soneri Bank and United Bank, had lapsed or were mid-renewal at the time of filing.

 KTrade Securities, the Consultant to the Issue that built the valuation case investors are being asked to buy into, is also one of the underwriters earning commission on the same deal.

The export-concentration risk this report keeps returning to is not hypothetical anymore either: the prospectus's own footnote confirms 9MFY26 exports fell on Pakistan-Afghanistan trade tensions, with Rayan Adnan Trading's purchases dropping from PKR 1,141mn in FY25 to just PKR 183mn nine months into FY26.

And the promoter family's footprint outside APAG turns out to be wider than the single disclosed related-party transaction suggests, 13 associated companies in total, including two other listed entities and a cluster of real estate developers tied to the Danish Elahi family.

3.5 Red Flags & Concerns

The most serious issue is the valuation itself. Run the prospectus's own DCF back through its own formulas, correcting for arbitrage income counted twice and a beta that flatters the risk profile, and fair value lands around PKR 31 a share, a hair under the floor, not 31% below it. Everything else compounds from there.

The capacity expansion consuming a quarter of the raise is being funded against three straight years of sub-46% utilization, not against any real capacity constraint. And the earnings underpinning the entry multiple lean more on a treasury-arbitrage strategy than on the edible-oil business itself, that strategy is no longer a one-off, either: roughly 42% of FY25's finance cost now ties directly to funding it.

Ownership and governance raise a second, separate set of questions. Sponsors have confirmed, plainly, that there's no plan to widen the free float, and a right-of-first-refusal keeps the Danish Elahi family's stake inside the insider circle even if it's ever sold, so the roughly 85% insider control on show today is likely to persist. On the board itself, the Executive Chairman sits on a three-person Audit Committee and the CFO sits on the committee that sets management's own pay; neither point was addressed when we asked about it directly.

A few smaller items round out the list. The FY25 inventory build was defended to us on profitability grounds, not cash flow, and the quick ratio sits at a thin 0.52x. Contracts for the ~PKR 1.4bn capex programme are still described as being at an 'advanced stage,' with no firm date or named contractor. And while APAG's own account of internal processing redundancy softens the single-site risk somewhat, it doesn't remove it, this is still one facility, in one city, exposed to one bad year.

3.6 Green Flags & Opportunities

None of this erases what APAG actually is: a business that's been making Soya Supreme, Taqat and Champion for 45 years, with real brand recall, a clean audit trail across FY23-FY25, and zero overdue loans. Leverage has genuinely come down, debt-to-equity fell from 77.66% in FY23 to 44.73% by 9MFY26, and the one related-party liability this report scrutinized most closely, the PKR 109.341mn GIDC exposure, is already sitting on the balance sheet as a provision, not hanging off it as an open risk.

It's also, structurally, a clean primary issue: every rupee raised goes into the company, not into a sponsor's pocket, and the floor-price multiple of 12.26x isn't obviously rich against a food-sector median of 15.08x.

Where the case for upside gets more interesting is in what management is already doing, not just promising.

The export book is genuinely diversifying, a new UAE customer and a Turkish exclusivity arrangement are real, not aspirational, and the capacity plan is at least aimed at more than one source of demand: local growth, new export markets, and institutional tenders with the WFP, Army and Navy.

Newer, higher-margin lines like Soya Supreme Olive Cooking Oil offer a route to better margins that doesn't depend on the capacity expansion at all. And nine months into FY26, profit has already overtaken all of FY25, an improvement that's real, even if some of what's driving it deserves the scrutiny this report has given it.

4. Management's Responses — Verbatim

Reproduced exactly as received from APAG's CEO, unedited.

A. Valuation & Pricing

Q: The DCF implies PKR 46.49/share while the peer-multiple method implies PKR 56.14, a ~20% gap between your own two methodologies. Which do you consider the more defensible anchor, and why was a premium-FMCG peer set (Nestlé, Unilever, National Foods) used for the 'fair value' framing rather than closer commodity-processing peers?

Q: Your FY26–FY32 projections assume EBIT margin nearly doubling from 7.3% to 10.7% alongside sustained double-digit revenue growth. What specific, already-contracted initiatives, beyond the capacity add itself, underpin that margin expansion? What does the DCF value become if margin simply holds at FY25's 6.28%?

Q: FY25's other income of PKR 239.4mn, including PKR 217.7mn from treasury arbitrage on short-term borrowings, contributed roughly a third of the year's PAT. Is this strategy repeatable, and should investors strip it out when judging underlying operating earnings power?

B. Cash Flow & Balance Sheet

Q: Operating cash flow went negative (−PKR 296.6mn) in FY25 even as profit rose. Walk us through the inventory build in detail — has it converted to cash on schedule, and does the quick ratio of 0.52x concern the Board?

Q: Short-term borrowings are partly funding the TDR/mutual-fund arbitrage described above. Has the Board formally reviewed and endorsed borrowing to invest in short-term securities, rather than deploying that borrowing directly into operations?

Q: Finance costs of PKR 448.6mn consumed nearly 40% of FY25 operating profit. Is any portion of IPO proceeds — beyond the disclosed CAPEX/working-capital/marketing split — earmarked to retire short-term debt, and if not, why not?

C. Related-Party & Governance

Q: The Executive Chairman sits as a voting member of the Audit Committee alongside one independent director. What compensating controls ensure independent oversight of related-party transactions, including the PKR 27mn office purchase from Director Amyn? / Was an independent third-party valuation obtained for that PKR 27mn property purchase, and can it be shared with prospective investors?

Q: Two of your three non-family directors joined the Board only in 2026, shortly before this listing. What has their substantive engagement with strategy and controls looked like to date, beyond pre-IPO preparatory meetings?

Q: Four separate proceedings involving minority shareholder Mr. Mohammad Saleheen Siddique remain open, including a live 2025 challenge to the current Board's election. What is the substance of the underlying dispute, and could an adverse ruling affect the validity of Board decisions taken since 2021 — including decisions relevant to this IPO?

Q: Shares belonging to two deceased shareholders remain unclaimed more than a decade after their deaths. What steps has the Company taken toward resolving succession, and could unresolved heir claims create post-listing disputes over those shares?

D. Concentration & Operational Risk

Q: A single Afghan buyer represented 73% of FY25 export sales. What contingency exists if that relationship deteriorates, and how exposed is the Company to the Pakistan-Afghanistan border disruptions flagged in your own risk factors?

Q: All production runs through one Karachi site with no backup facility, and the expansion itself will be built there while the plant keeps running. What continuity plan and business-interruption insurance are in place during construction?

Q: Contractors and vendors for the ~PKR 1.4bn CAPEX aren't yet finalized. What's the realistic contracting timeline, and what cost-overrun buffer exists if quotes move before agreements are signed?

E. Post-Listing Structure & Float

Q: Post-IPO, sponsors/directors plus the Danish Elahi family group will together control roughly 85% of the Company. What is the roadmap, if any, for increasing genuine free float and secondary-market liquidity once the lock-in period ends?

Q: The share capital was split 1:50 in April 2026, four months before this filing. Beyond retail-affordability optics, is there any other rationale for the timing?

F. Legal & Regulatory

Q: Beyond the PKR 184.5mn aggregate exposure disclosed across the eight pending cases, are any provisions already booked in the financial statements against these matters, and if not, why not?

Q: The GIDC (2015) and Excise & Taxation (1997) disputes have run for a decade or more. What is management's realistic view on resolution timeline, and could listed-company scrutiny change either regulator's posture? / The GIDC amount of PKR 109.341mn appears as a provision within Trade and Other Payables in the audited accounts, rather than in the Contingencies note alongside your other disputed matters. Has this amount been fully accounted for and adjusted in the Company's final reported numbers, net income, equity, and payables for FY24 and FY25, or does it remain a balance-sheet placeholder that could still move if the litigation resolves adversely?

5. How the Answers Hold Up

6. Bottom Line

Management engaged seriously here, and answered more directly than evasively. Several genuine concerns were resolved along the way: Board approval of the arbitrage strategy, an independent valuation on the related-party deal, the Siddique litigation no longer threatening the listing, and GIDC confirmed as already provisioned.

But running the prospectus's own numbers back through its own formulas tells the sharper story. The DCF's 31% discount survives only if you accept a beta that treats APAG as less risky than the market despite a 90%-dollarized cost base, and only if you do not notice arbitrage income counted twice in the valuation bridge. Correct either one, and the floor stops looking like a discount, it lands close to fair value.

None of this makes APAG a bad company. It's a real, 45-year-old business with a clean audit trail and room to grow. But it does mean the floor price isn't the bargain it's been framed as, so investors weighing this issue shouldn't be bidding up expecting a discount that is not really there. If you are participating, go in treating PKR 32.00 as a fair price for a solid, low-margin business, and let the company earn a higher valuation through execution over the next few years, not through a story told at the roadshow.